Medacta Group Management

Management criteria checks 4/4

Medacta Group's CEO is Francesco Siccardi, appointed in Nov 2018, has a tenure of 5.33 years. total yearly compensation is €1.86M, comprised of 21.3% salary and 78.7% bonuses, including company stock and options. directly owns 19.9% of the company’s shares, worth CHF483.81M. The average tenure of the management team and the board of directors is 10.7 years and 5.2 years respectively.

Key information

Francesco Siccardi

Chief executive officer

€1.9m

Total compensation

CEO salary percentage21.3%
CEO tenure5.3yrs
CEO ownership19.9%
Management average tenure10.7yrs
Board average tenure5.2yrs

Recent management updates

Recent updates

Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?

Feb 22
Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?

Medacta Group (VTX:MOVE) Will Be Hoping To Turn Its Returns On Capital Around

Feb 07
Medacta Group (VTX:MOVE) Will Be Hoping To Turn Its Returns On Capital Around

Getting In Cheap On Medacta Group SA (VTX:MOVE) Might Be Difficult

Dec 18
Getting In Cheap On Medacta Group SA (VTX:MOVE) Might Be Difficult

Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)

Dec 04
Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)

Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?

Nov 15
Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?

Returns On Capital Signal Tricky Times Ahead For Medacta Group (VTX:MOVE)

Oct 30
Returns On Capital Signal Tricky Times Ahead For Medacta Group (VTX:MOVE)

If EPS Growth Is Important To You, Medacta Group (VTX:MOVE) Presents An Opportunity

Oct 17
If EPS Growth Is Important To You, Medacta Group (VTX:MOVE) Presents An Opportunity

Is Medacta Group (VTX:MOVE) Using Too Much Debt?

Sep 29
Is Medacta Group (VTX:MOVE) Using Too Much Debt?

Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)

Aug 11
Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)

Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?

Jul 27
Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?

Be Wary Of Medacta Group (VTX:MOVE) And Its Returns On Capital

Jul 03
Be Wary Of Medacta Group (VTX:MOVE) And Its Returns On Capital

At CHF117, Is It Time To Put Medacta Group SA (VTX:MOVE) On Your Watch List?

Apr 28
At CHF117, Is It Time To Put Medacta Group SA (VTX:MOVE) On Your Watch List?

Is Medacta Group (VTX:MOVE) A Risky Investment?

Apr 08
Is Medacta Group (VTX:MOVE) A Risky Investment?

Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?

Dec 25
Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?

Capital Allocation Trends At Medacta Group (VTX:MOVE) Aren't Ideal

Dec 09
Capital Allocation Trends At Medacta Group (VTX:MOVE) Aren't Ideal

Does Medacta Group (VTX:MOVE) Have A Healthy Balance Sheet?

Nov 09
Does Medacta Group (VTX:MOVE) Have A Healthy Balance Sheet?

Why Medacta Group SA (VTX:MOVE) Could Be Worth Watching

Sep 16
Why Medacta Group SA (VTX:MOVE) Could Be Worth Watching

The Returns On Capital At Medacta Group (VTX:MOVE) Don't Inspire Confidence

Aug 20
The Returns On Capital At Medacta Group (VTX:MOVE) Don't Inspire Confidence

Here's Why Medacta Group (VTX:MOVE) Has Caught The Eye Of Investors

Jul 02
Here's Why Medacta Group (VTX:MOVE) Has Caught The Eye Of Investors

Should You Think About Buying Medacta Group SA (VTX:MOVE) Now?

May 28
Should You Think About Buying Medacta Group SA (VTX:MOVE) Now?

Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return

May 12
Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return

These 4 Measures Indicate That Medacta Group (VTX:MOVE) Is Using Debt Reasonably Well

Mar 31
These 4 Measures Indicate That Medacta Group (VTX:MOVE) Is Using Debt Reasonably Well

Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?

Mar 17
Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?

Capital Investments At Medacta Group (VTX:MOVE) Point To A Promising Future

Feb 07
Capital Investments At Medacta Group (VTX:MOVE) Point To A Promising Future

Should You Investigate Medacta Group SA (VTX:MOVE) At CHF133?

Dec 10
Should You Investigate Medacta Group SA (VTX:MOVE) At CHF133?

Medacta Group (VTX:MOVE) Knows How To Allocate Capital

Nov 05
Medacta Group (VTX:MOVE) Knows How To Allocate Capital

Here's Why Medacta Group (VTX:MOVE) Can Manage Its Debt Responsibly

Sep 30
Here's Why Medacta Group (VTX:MOVE) Can Manage Its Debt Responsibly

Is It Too Late To Consider Buying Medacta Group SA (VTX:MOVE)?

Aug 26
Is It Too Late To Consider Buying Medacta Group SA (VTX:MOVE)?

Medacta Group (VTX:MOVE) May Have Issues Allocating Its Capital

Jul 20
Medacta Group (VTX:MOVE) May Have Issues Allocating Its Capital

Should You Investigate Medacta Group SA (VTX:MOVE) At CHF119?

May 19
Should You Investigate Medacta Group SA (VTX:MOVE) At CHF119?

We Think Medacta Group (VTX:MOVE) Can Stay On Top Of Its Debt

Apr 05
We Think Medacta Group (VTX:MOVE) Can Stay On Top Of Its Debt

What You Need To Know About Medacta Group SA's (VTX:MOVE) Investor Composition

Mar 02
What You Need To Know About Medacta Group SA's (VTX:MOVE) Investor Composition

Is Medacta Group SA's (VTX:MOVE) 7.6% ROE Better Than Average?

Feb 02
Is Medacta Group SA's (VTX:MOVE) 7.6% ROE Better Than Average?

The Medacta Group (VTX:MOVE) Share Price Has Gained 24% And Shareholders Are Hoping For More

Jan 12
The Medacta Group (VTX:MOVE) Share Price Has Gained 24% And Shareholders Are Hoping For More

Returns On Capital At Medacta Group (VTX:MOVE) Paint An Interesting Picture

Dec 21
Returns On Capital At Medacta Group (VTX:MOVE) Paint An Interesting Picture

Should You Use Medacta Group's (VTX:MOVE) Statutory Earnings To Analyse It?

Dec 03
Should You Use Medacta Group's (VTX:MOVE) Statutory Earnings To Analyse It?

CEO Compensation Analysis

How has Francesco Siccardi's remuneration changed compared to Medacta Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023€2m€396k

€47m

Sep 30 2023n/an/a

€49m

Jun 30 2023n/an/a

€50m

Mar 31 2023n/an/a

€48m

Dec 31 2022€2m€372k

€46m

Sep 30 2022n/an/a

€47m

Jun 30 2022n/an/a

€47m

Mar 31 2022n/an/a

€49m

Dec 31 2021€2m€354k

€52m

Sep 30 2021n/an/a

€54m

Jun 30 2021n/an/a

€57m

Mar 31 2021n/an/a

€47m

Dec 31 2020€1m€339k

€37m

Sep 30 2020n/an/a

€24m

Jun 30 2020n/an/a

€10m

Mar 31 2020n/an/a

€11m

Dec 31 2019€843k€247k

€12m

Compensation vs Market: Francesco's total compensation ($USD2.03M) is about average for companies of similar size in the Swiss market ($USD1.69M).

Compensation vs Earnings: Francesco's compensation has been consistent with company performance over the past year.


CEO

Francesco Siccardi (46 yo)

5.3yrs

Tenure

€1,861,824

Compensation

Dr. Francesco Siccardi has been Chief Executive Officer of Medacta Group SA since November 1, 2018. He is a Member of the Board of Directors of Surgical Practice Resource Group SA, Lugano since 2015 and of...


Leadership Team

NamePositionTenureCompensationOwnership
Alberto Siccardi
Founder & Non Executive Chairman6.2yrs€352.21k10.2%
€ 247.9m
Francesco Siccardi
Chief Executive Officer5.3yrs€1.86m19.9%
€ 483.8m
Corrado Farsetta
Chief Financial Officer13.2yrsno datano data
Gianluca Olgiati
Senior Director of Global Marketingno datano datano data
Asif Hussain
Chief People Officerno datano datano data
Alessandro Siccardi
Chief Supply Chain Officer8.2yrsno data19.8%
€ 481.4m
Filippo Cappelli
Head of ITno datano datano data
Giovanni Galli
Chief Commercial Officerno datano datano data
Massimiliano Bernardoni
Chief Innovation Officerno datano datano data
Donato Cortesi
Secretary of the Boardno datano datano data

10.7yrs

Average Tenure

50.5yo

Average Age

Experienced Management: MOVE's management team is seasoned and experienced (10.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Alberto Siccardi
Founder & Non Executive Chairman6.2yrs€352.21k10.2%
€ 247.9m
Victor Balli
Lead Independent Director5.2yrs€231.19k0.013%
€ 305.1k
Riccardo Braglia
Independent Director3.3yrs€128.89k0.16%
€ 4.0m
Philippe Weber
Independent Director5yrs€152.33kno data
Maria Siccardi Tonolli
Non-executive Director6.2yrs€137.62k19.8%
€ 481.4m

5.2yrs

Average Tenure

63yo

Average Age

Experienced Board: MOVE's board of directors are considered experienced (5.2 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.